"The entrepreneurial spirit of our founder and Principal, Dr. Charles Jost, Interventional Cardiologist has enabled us to expanding our medical service portfolio, which has led us to build our new ASC facility “Southwest CardioVascular Interventional Center” located at: 7529 E. Broadway Road Mesa, AZ 85208. We believe our Surgical Center will allow us to safely address the necessary changes our healthcare industry demands, and will enable us to foster a culture of clinical innovation in a center of excellence uniquely designed to, diversify Cardiology/Cardiovascular, Electrophysiology, and Interventional Radiology procedures in one environment."

During the past decade, Southwest Cardiovascular Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest Cardiovascular Associates" #1 sponsor was "Impulse Dynamics" with 4 trials, followed by "MicroPort CRM" with 2 trials sponsored, "AngioSafe, Inc." with 1 trials sponsored, "CVRx, Inc." with 1 trials sponsored and "ELA Medical, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Cardiovascular Associates" #1 collaborator was "Veranex, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Cardiovascular Associates" are "Heart Failure" (6 trials), "CHF" (2 trials), "Chronic Heart Disease" (2 trials), "Congestive Heart Failure" (2 trials) and "Atrial Arrhythmia" (1 trials). Many other conditions were trialed in "Southwest Cardiovascular Associates" in a lesser frequency.

Most popular intervention types in "Southwest Cardiovascular Associates" are "Device" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AngioSafe Peripheral CTO Crossing System" (1 trials), "BAROSTIM NEO® System" (1 trials), "Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System" (1 trials), "OPTIMIZER Smart System" (1 trials) and "OPTIMIZER™ Smart Mini System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Cardiovascular Associates" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Southwest Cardiovascular Associates". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Southwest Cardiovascular Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Cardiovascular Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".